Nuclear Medicine: Page 100

Lantheus plans secondary offering of 3M shares

By AuntMinnie.com staff writers

Lantheus Holdings said that certain of its existing stockholders will sell 3 million shares of its common stock in a public secondary offering.

March 13, 2017

MRI debunks 'liberation therapy' | PET/CT guides pediatric cancer biopsy | 8 ways to win turf battles

By Brian Casey

March 8, 2017

Piramal partner gets Canadian approval for Neuraceq

By AuntMinnie.com staff writers

Piramal Imaging's partner in Canada has received marketing authorization from Health Canada to begin commercial production and distribution of its Neuraceq radiotracer for diagnosing Alzheimer's disease.

March 7, 2017

Novel PET tracer aids recurrent prostate cancer patients

By Wayne Forrest

A study in the March issue of the Journal of Nuclear Medicine is touting the PET radiotracer fluciclovine F-18 for its ability to guide and monitor targeted treatment for recurrent prostate cancer.

March 7, 2017

FDG-PET/CT can direct biopsies for pediatric cancer

By Wayne Forrest

FDG-PET/CT can play a valuable role in directing image-guided biopsies of pediatric cancer patients, given its ability to detect and discern between malignant and benign regions, according to a study by a group from Saudi Arabia and Canada published in the March issue of the American Journal of Roentgenology.

March 7, 2017

AuntMinnie.com Molecular Imaging Insider

By Wayne Forrest

March 5, 2017

New PET tracer shows promise for atherosclerosis

By AuntMinnie.com staff writers

European researchers have developed a PET tracer that has shown the ability to quickly and noninvasively identify life-threatening atherosclerotic plaques, according to a study published in the March issue of the Journal of Nuclear Medicine.

March 1, 2017

DMS deal powers Digirad's 2016 numbers

By AuntMinnie.com staff writers

Nuclear medicine firm Digirad saw its revenues double for the fourth quarter and full year of 2016, thanks to its acquisition of DMS Health last year.

February 23, 2017

Lantheus inks deal with GE for flurpiridaz PET tracer

By AuntMinnie.com staff writers

Lantheus Medical Imaging has signed a term sheet with GE Healthcare to support the worldwide development and commercialization of its flurpiridaz F-18 investigational PET radiopharmaceutical.

February 21, 2017

Medicare coverage gets easier for oncologic PET tracers

By Terri Wilson

In September 2013, Medicare coverage for new oncologic PET radiopharmaceuticals underwent a quiet yet significant change. In a new column, Terri Wilson of Blue Earth Diagnostics explains how the changes are making it easier for providers to receive reimbursement for PET studies with the new radiotracers.

February 16, 2017

Radiopharmaceuticals market slated for strong growth

By AuntMinnie.com staff writers

The global radiopharmaceuticals market generated $4.8 billion in revenues in 2016 and is expected to increase at a 5.9% compound annual growth rate to reach $8.5 billion by 2026, according to a new report by market research firm Future Market Insights.

February 13, 2017

Blue Earth, PETNet expand Axumin distribution

By AuntMinnie.com staff writers

Radiopharmaceutical developer Blue Earth Diagnostics and Siemens Healthineers subsidiary PETNet Solutions said they have increased the number of radiopharmacies offering Blue Earth's Axumin PET radiopharmaceutical.

February 6, 2017

Previous Page

Page 100 of 440

Next Page